Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane?
Purpose: To describe the long-term outcome of a patient with multifocal choroiditis, who underwent surgical removal of a type 2 choroidal neovascular membrane employing 23 G pars plana vitrectomy. Observations: A 50-year-old man was treated with 3 monthly intravitreal bevacizumab injections, but des...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-09-01
|
| Series: | American Journal of Ophthalmology Case Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993618301476 |
| _version_ | 1818858685805363200 |
|---|---|
| author | Hugo Quiroz-Mercado Andrés Lisker-Cervantes Luis Arroyo Naresh Mandava Frank S. Siringo Miguel Paciuc-Beja Roberto Gonzalez-Salinas |
| author_facet | Hugo Quiroz-Mercado Andrés Lisker-Cervantes Luis Arroyo Naresh Mandava Frank S. Siringo Miguel Paciuc-Beja Roberto Gonzalez-Salinas |
| author_sort | Hugo Quiroz-Mercado |
| collection | DOAJ |
| description | Purpose: To describe the long-term outcome of a patient with multifocal choroiditis, who underwent surgical removal of a type 2 choroidal neovascular membrane employing 23 G pars plana vitrectomy. Observations: A 50-year-old man was treated with 3 monthly intravitreal bevacizumab injections, but despite treatment, visual acuity continued to worsen from 20/40 to 20/100, and bleeding was not receding. A minimal invasive pars plana vitrectomy was performed for surgical removal of the neovascular complex without any complicating incident. Subsequent visual acuity was 20/25 for more than eleven years. Conclusions and Importance: Surgical removal of choroidal neovascular membranes employing minimal invasive surgery in addition to anti-VEGF therapy, and OCT evaluation can be a viable approach for selected cases of juxtafoveal type 2 CNV. Keywords: Choroidal neovascular membrane, Spectral-domain optical coherence tomography, Pars plana vitrectomy, Anti-VEGF therapy |
| first_indexed | 2024-12-19T09:00:13Z |
| format | Article |
| id | doaj.art-cb535f21231343c6af3e11c1842f277e |
| institution | Directory Open Access Journal |
| issn | 2451-9936 |
| language | English |
| last_indexed | 2024-12-19T09:00:13Z |
| publishDate | 2019-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | American Journal of Ophthalmology Case Reports |
| spelling | doaj.art-cb535f21231343c6af3e11c1842f277e2022-12-21T20:28:30ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362019-09-0115Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane?Hugo Quiroz-Mercado0Andrés Lisker-Cervantes1Luis Arroyo2Naresh Mandava3Frank S. Siringo4Miguel Paciuc-Beja5Roberto Gonzalez-Salinas6Research Department, Asociación para Evitar la Ceguera, IAP, Mexico City, PO 04030, Mexico; University of Colorado, Denver, CO. United States; Corresponding author. Research Department, Asociación para Evitar la Ceguera I.A.P, Vicente García Torres 46, Barrio San Lucas, Coyoacán, CP 04030, Mexico City, Mexico. Tel.:+720 4250230.Retina Department, Asociación para Evitar la Ceguera, IAP, Mexico City, PO 04030, MexicoRetina Department, Asociación para Evitar la Ceguera, IAP, Mexico City, PO 04030, MexicoUniversity of Colorado, Denver, CO. United StatesUniversity of Colorado, Denver, CO. United StatesUniversity of Colorado, Denver, CO. United StatesResearch Department, Asociación para Evitar la Ceguera, IAP, Mexico City, PO 04030, MexicoPurpose: To describe the long-term outcome of a patient with multifocal choroiditis, who underwent surgical removal of a type 2 choroidal neovascular membrane employing 23 G pars plana vitrectomy. Observations: A 50-year-old man was treated with 3 monthly intravitreal bevacizumab injections, but despite treatment, visual acuity continued to worsen from 20/40 to 20/100, and bleeding was not receding. A minimal invasive pars plana vitrectomy was performed for surgical removal of the neovascular complex without any complicating incident. Subsequent visual acuity was 20/25 for more than eleven years. Conclusions and Importance: Surgical removal of choroidal neovascular membranes employing minimal invasive surgery in addition to anti-VEGF therapy, and OCT evaluation can be a viable approach for selected cases of juxtafoveal type 2 CNV. Keywords: Choroidal neovascular membrane, Spectral-domain optical coherence tomography, Pars plana vitrectomy, Anti-VEGF therapyhttp://www.sciencedirect.com/science/article/pii/S2451993618301476 |
| spellingShingle | Hugo Quiroz-Mercado Andrés Lisker-Cervantes Luis Arroyo Naresh Mandava Frank S. Siringo Miguel Paciuc-Beja Roberto Gonzalez-Salinas Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane? American Journal of Ophthalmology Case Reports |
| title | Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane? |
| title_full | Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane? |
| title_fullStr | Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane? |
| title_full_unstemmed | Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane? |
| title_short | Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane? |
| title_sort | is subretinal surgery feasible for a non responsive juxtafoveal type 2 choroidal neovascular membrane |
| url | http://www.sciencedirect.com/science/article/pii/S2451993618301476 |
| work_keys_str_mv | AT hugoquirozmercado issubretinalsurgeryfeasibleforanonresponsivejuxtafovealtype2choroidalneovascularmembrane AT andresliskercervantes issubretinalsurgeryfeasibleforanonresponsivejuxtafovealtype2choroidalneovascularmembrane AT luisarroyo issubretinalsurgeryfeasibleforanonresponsivejuxtafovealtype2choroidalneovascularmembrane AT nareshmandava issubretinalsurgeryfeasibleforanonresponsivejuxtafovealtype2choroidalneovascularmembrane AT frankssiringo issubretinalsurgeryfeasibleforanonresponsivejuxtafovealtype2choroidalneovascularmembrane AT miguelpaciucbeja issubretinalsurgeryfeasibleforanonresponsivejuxtafovealtype2choroidalneovascularmembrane AT robertogonzalezsalinas issubretinalsurgeryfeasibleforanonresponsivejuxtafovealtype2choroidalneovascularmembrane |